SCIMITAR EQUITY
About Us Equity Research Disclosure Contact







Regulatory Disclosure

Reg, AC, Analysts Certification


Company Specific Disclosure


Regulatory Disclosure


Legal Disclaimer


Estimates, Models and Valuation Methodology


Managing Conflicts of Interest
in Equity Research


Transparency of Analyst's Performance


Compensation for Product and Services Disclosures


Investment Suitability


Research Coverage Universe


Stock Ranking System


Distribution of Rankings


Company Ranking Time
Definition


Research Dissemination


Valuation Methodology


Earnings and Price Disclosures


Privacy Policy


Disclosures Supporting Reporting



Regulatory Disclosure

print this page

Scimitar Equity, LLC (Scimitar) is an equity research firm providing unbiased and insightful analysis for under-followed and small capitalization health science companies. Scimitar is a publisher of investment research utilizing the "sponsored" or "paid-for" compensation model to increase visibility and access for these sector specific companies. Scimitar "clearly and prominently" articulates a statement of financial sponsorship and has a compensation arrangement for these informational ($25,000), quarterly ($8,500) and mid-quarter ($4,500) research reviews. Scimitar provides qualitative scientific and financial analyses to identify those companies demonstrating real progress towards their vision while meeting quarterly expectations. Scimitar delivers this research and analysis of selected segments within the health/life science industry via the world-wide web and our proprietary database to the institutional, advisory and retail investment communities. To maximize transparency in analyst certification, we are required to disclose any potential conflicts of interest thus insuring independence. We do not accept payment of any fees in company stock or any form of security.

Investment Banking Services Are Not Offered or Actualized
Scimitar Equity, LLC will not have any investment banking relationships with any company to maintain our independence and objectivity. Scimitar is not registered as a securities broker-dealer or an investment advisor either with the SEC or with any state securities regulatory agencies.

Beneficial Ownership Disclosure
Pre and post our quarterly reporting, Scimitar Equity, LLC does not and will not own any securities related to companies we provide analysis or develop research products. We do not accept payment of any fees in company stock or any form of security as any receipt or disposal of any security under such alternative payment methods will compromise the objectivity and integrity of any company review or updates produced. We prohibit our analysts, persons reporting to analysts and members of their households from maintaining any financial interest in the securities of any company that we provide research sponsorship. Scimitar will not own any securities related to the companies we provide analysis or develop research products.

Analyst Investment Certification and Holdings
As an analyst and the Director of Research, Henry W. McCusker does not and will not own securities related to the companies he provide analysis or develop research products. Henry's name will appear on every research review that he generates certifying his personal belief about the individual security. Henry McCusker's compensation is not and will not be related to any recommendation or price target ranking in researching the equity reviews produced by Scimitar Equity, LLC.